Lee Sung bought CYTK
July 1, 2026 · Form 4 insider transaction
Lee Sung bought 1,112 shares of Cytokinetics, Incorporated at $48.51 per share, a transaction worth $53.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
1,112
Price
$48.51
Total value
$53.9K
InsiderLee Sung
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 1, 2026
Filing dateJuly 2, 2026
Shares owned after64,333
OwnershipDirect
10b5-1 planNo
AmendedNo